{"content":"<li class=\"n-box-item date-title\" data-end=\"1560571199\" data-start=\"1560484800\" data-txt=\"Monday, December 23, 2019\">Friday, June 14, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3471596\" data-ts=\"1560550609\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471596-dish-in-pole-position-to-scoop-sprint-t-mobile-assets-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish in pole position to scoop Sprint/T-Mobile assets - WSJ</a></h4><ul>   <li>The <a href=\"https://seekingalpha.com/news/3471492-dish-network-still-pressing-case-sprint-t-mobile-merger\" target=\"_blank\">reported meeting</a> between Dish Network's (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>) Charlie Ergen and DOJ's Makan Delrahim and FCC's Ajit Pai wasn't just passing time: The <i>WSJ</i> reports Ergen and Dish are leaders in the <a href=\"https://www.wsj.com/articles/in-sprint-t-mobile-merger-talks-power-shifts-to-a-familiar-agitator-11560544163?shareToken=st12fb58194d3c4bfcb633cacee20fb692\" target=\"_blank\">hunt to scoop up cast-off assets</a> from Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) and T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) as the two carriers look to save their $26B merger.</li>    <li>After arguing against the combo, Ergen is now looking to help out by picking up business, and he's in talks to buy prepaid subscribers and spectrum licenses, according to the report. Talks are expected to go through the weekend.</li>    <li>Meanwhile, Sprint and T-Mobile jumped this afternoon following a <i>NYT</i> report that the Justice Dept. is <a href=\"https://seekingalpha.com/news/3471532-sprint-t-mobile-jump-report-doj-close-approving-merger\" target=\"_blank\">nearing approval of the merger</a> provided that Sprint's prepaid arm Boost Mobile and related airwaves are sold off.</li>    <li>At market close: Sprint <font color=\"green\">+2.9%</font>; T-Mobile <font color=\"green\">+0.6%</font>; Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications Inc.'>VZ</a>) <font color=\"green\">+1.2%</font>; AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) <font color=\"green\">+0.2%</font>. Dish finished the regular session <font color=\"red\">down 0.9%</font> but is now <font color=\"green\">up 1.7%</font> after hours.</li>    <li>Dish might be more likely to keep assets together as the DOJ wishes, and it's under the gun to put its wireless spectrum hoard to use or risk losing licenses.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471596\" data-linked=\"Dish in pole position to scoop Sprint/T-Mobile assets - WSJ\" data-tweet=\"$DISH $S $TMUS - Dish in pole position to scoop Sprint/T-Mobile assets - WSJ https://seekingalpha.com/news/3471596-dish-in-pole-position-to-scoop-sprint-t-mobile-assets-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3471596-dish-in-pole-position-to-scoop-sprint-t-mobile-assets-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471589\" data-ts=\"1560548797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471589-sgmo-crsp-epzm-and-hear-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SGMO, CRSP, EPZM and HEAR among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a> <font color=\"green\">+3.3%</font>. <a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme, Inc.'>EPZM</a> <font color=\"green\">+2.1%</font>. <a href='https://seekingalpha.com/symbol/ACA' title='Arcosa, Inc.'>ACA</a> <font color=\"green\">+2.1%</font>. <a href='https://seekingalpha.com/symbol/FVRR' title='Fiverr International Ltd.'>FVRR</a> <font color=\"green\">+1.9%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color=\"green\">+1.6%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a> <font color=\"red\">-2.9%</font>. <a href='https://seekingalpha.com/symbol/NEW' title='Puxin Limited'>NEW</a> <font color=\"red\">-2.7. </font><a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color=\"red\">-2.1%</font>. <a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a> <font color=\"red\">-1.8%</font>. <a href='https://seekingalpha.com/symbol/NNBR' title='NN, Inc.'>NNBR</a> <font color=\"red\">-1.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471589\" data-linked=\"SGMO, CRSP, EPZM and HEAR among notable after hour movers\" data-tweet=\"$HCHC $EPZM $ACA - SGMO, CRSP, EPZM and HEAR among notable after hour movers https://seekingalpha.com/news/3471589-sgmo-crsp-epzm-and-hear-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471589-sgmo-crsp-epzm-and-hear-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471586\" data-ts=\"1560547948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRKR\" target=\"_blank\">MRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471586-marker-therapeuticsminus-3_5-after-200m-mixed-shelf\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marker Therapeutics -3.5% after $200M mixed shelf</a></h4><ul>   <li>Marker Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics, Inc.'>MRKR</a>) is <font color=\"red\">3.5% lower</font> postmarket after the filing of a <a href=\"https://seekingalpha.com/filing/4533275\" target=\"_blank\">$200M mixed shelf registration</a>.</li>    <li>That might include common stock, preferred stock, debt securities and warrants from time to time, according to the filing.</li>    <li>Aside from later more specific uses, the company is designating proceeds to be used for working capital, capex and general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471586\" data-linked=\"Marker Therapeutics -3.5% after $200M mixed shelf\" data-tweet=\"$MRKR - Marker Therapeutics -3.5% after $200M mixed shelf https://seekingalpha.com/news/3471586-marker-therapeuticsminus-3_5-after-200m-mixed-shelf?source=tweet\" data-url=\"https://seekingalpha.com/news/3471586-marker-therapeuticsminus-3_5-after-200m-mixed-shelf\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471584\" data-ts=\"1560547322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471584-turtle-beachplus-3_5-director-buys-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turtle Beach +3.5% as director buys shares</a></h4><ul>   <li>Turtle Beach (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) is <font color=\"green\">up 3.5%</font> after the latest disclosure of an insider buy: Boardmember Ronald Doornink <a href=\"https://seekingalpha.com/filing/4533432\" target=\"_blank\">bought 4,938 shares</a> yesterday.</li>    <li>Those came at an average price of $10.47, for an outlay of about $51,700.</li>    <li>Doornink now beneficially owns 4,132 shares directly, as well as 40,000 shares held by the Ron and Martha Doornink Foundation, and 378,886 held by the Doornink Revocable Living Trust.</li>    <li>The company's CEO and a director also <a href=\"https://seekingalpha.com/news/3470505-turtle-beach-plus-9-percent-insider-purchases\" target=\"_blank\">disclosed share purchases</a> earlier this week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471584\" data-linked=\"Turtle Beach +3.5% as director buys shares\" data-tweet=\"$HEAR - Turtle Beach +3.5% as director buys shares https://seekingalpha.com/news/3471584-turtle-beachplus-3_5-director-buys-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3471584-turtle-beachplus-3_5-director-buys-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471572\" data-ts=\"1560544635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471572-pyxus-international-reports-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pyxus International reports Q4 results</a></h4><ul><li>Pyxus International (NYSE:<a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a>): Q4 GAAP EPS of -$1.10.</li><li>Revenue of $591.24M (-8.2% Y/Y).</li><li>Shares <font color=\"green\">+1.36%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17545408-pyxus-international-inc-reports-fourth-quarter-fiscal-year-2019-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3471572\" data-linked=\"Pyxus International reports Q4 results\" data-tweet=\"$PYX - Pyxus International reports Q4 results https://seekingalpha.com/news/3471572-pyxus-international-reports-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3471572-pyxus-international-reports-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471566\" data-ts=\"1560544028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471566-weekly-etf-gainers-losers-06-14-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers (06/14/19)</a></h4><ul>     <li><b>Top gainers: </b><a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a> <font color=\"green\">+12.6%</font>. <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a> <font color=\"green\">+9.9%</font>. <a href='https://seekingalpha.com/symbol/PALL' title='ETFS Physical Palladium Shares ETF'>PALL</a> <font color=\"green\">+8.0%</font>. <a href='https://seekingalpha.com/symbol/RETL' title='Direxion Daily Retail Bull 3x Shares ETF'>RETL</a> <font color=\"green\">+7.4%</font>. <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a> <font color=\"green\">+7.1%</font> .</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a><font color=\"red\"> -13.2%</font>. <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a> <font color=\"red\">-11.0%</font>. <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a><font color=\"red\"> -8.5%</font>. <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a> <font color=\"red\">-8.3%</font>. <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a> <font color=\"red\">-8.3%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3471566\" data-linked=\"Weekly ETF Gainers / Losers (06/14/19)\" data-tweet=\"$GASX $DRIP $PALL - Weekly ETF Gainers / Losers (06/14/19) https://seekingalpha.com/news/3471566-weekly-etf-gainers-losers-06-14-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3471566-weekly-etf-gainers-losers-06-14-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471558\" data-ts=\"1560543374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMPE\" target=\"_blank\">AMPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471558-ampio-slides-22-after-proposing-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ampio slides 22% after proposing stock offering</a></h4><ul><li>Ampio Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a>)<font color=\"red\"> sinks 22%</font> in after-hours trading after announcing plans for a <a href=\"https://seekingalpha.com/pr/17545364-ampio-pharmaceuticals-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">common stock offering</a>.</li><li>Expects to grant greenshoe option for additional shares.</li><li>Intends to use proceeds for working capital and general corporate purposes, including funding for its AP-013 clinical trial.</li><li>Ampio didn't disclose the number of shares it plans to offer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3471351-ampio-moves-forward-ampion-protocol\" target=\"_blank\">Ampio moves forward with Ampion protocol</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3471558\" data-linked=\"Ampio slides 22% after proposing stock offering\" data-tweet=\"$AMPE - Ampio slides 22% after proposing stock offering https://seekingalpha.com/news/3471558-ampio-slides-22-after-proposing-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3471558-ampio-slides-22-after-proposing-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471548\" data-ts=\"1560542756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471548-analysts-stay-bullish-on-global-blood-therapeutics-say-selloff-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts stay bullish on Global Blood Therapeutics; say selloff overdone</a></h4><ul><li>Today's selloff in Global Blood Therapeutics (<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics, Inc.'>GBT</a> <font color=\"red\">-6.2%</font>) is <a href=\"https://thefly.com/thestreet/realmoney/index.php/GBTid2922431/GBT-Global-Blood-Therapeutics-selloff-today-is-overdone-says-Piper-Jaffray\" target=\"_blank\">overdone</a>, Piper Jaffray analyst Danielle Brill says after further clarification from <a href=\"https://seekingalpha.com/news/3471459-global-blood-sickle-cell-drug-data-passes-shares-minus-3_7-percent\" target=\"_blank\">today's voxelotor results</a>, particularly for vaso-occlusive crises, appear more in-line relative to previous reports.</li><li>GBT's new drug application submission remains on track for H2, Brill says, still expecting accelerated approval of voxelotor by H1 2020 with no FDA advisory panel meeting.</li><li>Analysts including Brill <a href=\"https://finance.yahoo.com/news/global-blood-therapeutics-stock-options-183720947.html\" target=\"_blank\">remain overwhelmingly bullish on GBT</a>: Piper keeps its Overweight rating and $80 price target on the shares, Guggenheim says it would be buyers on any weakness, and Cantor Fitzgerald raised its price target to $110 from $96.</li><li>GBT's average <a href=\"https://seekingalpha.com/symbol/GBT/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform and its average <a href=\"https://seekingalpha.com/symbol/GBT/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Very Bullish, while its <a href=\"https://seekingalpha.com/symbol/GBT/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471548\" data-linked=\"Analysts stay bullish on Global Blood Therapeutics; say selloff overdone\" data-tweet=\"$GBT - Analysts stay bullish on Global Blood Therapeutics; say selloff overdone https://seekingalpha.com/news/3471548-analysts-stay-bullish-on-global-blood-therapeutics-say-selloff-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3471548-analysts-stay-bullish-on-global-blood-therapeutics-say-selloff-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471543\" data-ts=\"1560542333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEET\" target=\"_blank\">MEET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471543-meet-group-refutes-short-seller-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meet Group refutes short-seller report</a></h4><ul><li>The Meet Group (<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a> <font color=\"red\">-3.8%</font>) <a href=\"https://seekingalpha.com/pr/17545340-meet-group-reaffirms-commitment-industry-leading-user-safety\" target=\"_blank\">says</a> it \"makes user safety a top priority\" after a short-seller report <a href=\"https://seekingalpha.com/article/4270258-meet-group-monetization-explicit-live-cam-content-threatens-app-store-revenues\" target=\"_blank\">warned</a> MEET's monetization of explicit live cam content threatens its App Store revenue</li><li>Meet says it devotes more than 45% of its workforce to regulating its app content and \"employs a variety of human and technological filters to monitor all visual content.\"</li><li>The company says it removes 3,000 user profiles per day as part of the content review process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471543\" data-linked=\"Meet Group refutes short-seller report\" data-tweet=\"$MEET - Meet Group refutes short-seller report https://seekingalpha.com/news/3471543-meet-group-refutes-short-seller-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3471543-meet-group-refutes-short-seller-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471540\" data-ts=\"1560542041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CF\" target=\"_blank\">CF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471540-adnoc-oci-in-talks-to-combine-mideast-fertilizer-assets-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adnoc, OCI in talks to combine Mideast fertilizer assets - Bloomberg</a></h4><ul><li>CF Industries (<a href='https://seekingalpha.com/symbol/CF' title='CF Industries Holdings, Inc.'>CF</a> <font color=\"green\">+2.1%</font>) is higher following a Bloomberg report that Abu Dhabi National Oil Corp. and Dutch chemical producer OCI (<a href='https://seekingalpha.com/symbol/OCINF' title='OCI N.V.'>OTC:OCINF</a>) are <a href=\"https://www.bloomberg.com/news/articles/2019-06-14/adnoc-oci-said-in-talks-to-combine-mideast-fertilizer-assets\" target=\"_blank\">in talks to merge their Middle East fertilizer assets</a>, with an agreement possibly ready in the coming days.</li><li>In response to the report, OCI \"confirms that it is in  discussions with ADNOC on a possible cooperation relating to each  company\u2019s MENA fertilizer assets.\"</li><li>CF abandoned a plan to buy OCI's nitrogen fertilizer business in 2016 after U.S. guidelines curbed its ability to use the deal to move its  headquarters to a more tax-friendly location.</li><li>Among other major fertilizer names: <a href='https://seekingalpha.com/symbol/NTR' title='Nutrien Ltd.'>NTR</a> <font color=\"green\">+0.5%</font>, <a href='https://seekingalpha.com/symbol/MOS' title='The Mosaic Company'>MOS</a> <font color=\"red\">-1.9%</font>, <a href='https://seekingalpha.com/symbol/IPI' title='Intrepid Potash, Inc.'>IPI</a> <font color=\"red\">-1.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471540\" data-linked=\"Adnoc, OCI in talks to combine Mideast fertilizer assets - Bloomberg\" data-tweet=\"$CF $OCINF $NTR - Adnoc, OCI in talks to combine Mideast fertilizer assets - Bloomberg https://seekingalpha.com/news/3471540-adnoc-oci-in-talks-to-combine-mideast-fertilizer-assets-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3471540-adnoc-oci-in-talks-to-combine-mideast-fertilizer-assets-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471532\" data-ts=\"1560539602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471532-sprint-t-mobile-jump-on-report-doj-close-to-approving-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint, T-Mobile jump on report DOJ close to approving merger</a></h4><ul>    <li>Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+4.1%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+1.5%</font>) have jumped in the past few minutes alongside a <i>New York Times</i> report that their <a href=\"https://www.nytimes.com/2019/06/14/technology/t-mobile-sprint-merger.html?searchResultPosition=3\" target=\"_blank\">merger is near approval</a> from the Justice Dept.</li>    <li>AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+0.3%</font>) and Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color=\"green\">+1.2%</font>) are also near session highs.</li><li>That approval will be conditioned on the sale of multiple assets to build a new wireless competitor, according to the report.</li>    <li>And such a plan would ding the <a href=\"https://seekingalpha.com/news/3470510-new-york-nine-ags-sue-block-sprint-t-mobile-merger\" target=\"_blank\">suit filed by 10 attorneys general</a> to stop the deal. The settlement could come in the coming week.</li>    <li>Sprint and T-Mobile have approached Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>), Charter (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) and Altice USA (NYSE:<a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA, Inc.'>ATUS</a>) about buying Boost Mobile (Sprint's prepaid service) and associated airwaves.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3471532\" data-linked=\"Sprint, T-Mobile jump on report DOJ close to approving merger\" data-tweet=\"$DISH $CHTR $ATUS - Sprint, T-Mobile jump on report DOJ close to approving merger https://seekingalpha.com/news/3471532-sprint-t-mobile-jump-on-report-doj-close-to-approving-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3471532-sprint-t-mobile-jump-on-report-doj-close-to-approving-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471526\" data-ts=\"1560538493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAXR\" target=\"_blank\">MAXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471526-maxar-exploring-sale-of-space-robotics-unit-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxar exploring sale of space robotics unit - Reuters</a></h4><ul><li>Maxar Technologies  (<a href='https://seekingalpha.com/symbol/MAXR' title='Maxar Technologies Inc.'>MAXR</a> <font color='green'>+7%</font>) is <a href=\"https://www.reuters.com/article/us-maxar-techno-macdonalddettwiler-exclu/exclusive-satellite-image-provider-maxar-eyes-sale-of-space-robotics-unit-sources-idUSKCN1TF2EX\" target=\"_blank\">considering a sale of its space robotics  business</a>, which could fetch more than $1B and allow it to pay  down some of its $3.2B debt pile, Reuters reports.</li><li>Shares have fallen 45% YTD following the failure of its WorldView-4 satellite in January.</li><li>MAXR makes defense and maritime systems, radar geospatial imagery, space  robotics, satellite antennas and communication subsystems.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471526\" data-linked=\"Maxar exploring sale of space robotics unit - Reuters\" data-tweet=\"$MAXR - Maxar exploring sale of space robotics unit - Reuters https://seekingalpha.com/news/3471526-maxar-exploring-sale-of-space-robotics-unit-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3471526-maxar-exploring-sale-of-space-robotics-unit-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471525\" data-ts=\"1560537850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471525-bluebirdminus-5_5-on-eu-zynteglo-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bluebird -5.5% on EU Zynteglo delay</a></h4><ul><li>Cowen analyst Yaron Werber says Bluebird (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) reported \"highly encouraging\" Zynteglo data at the EHA meeting and announced higher-than-expected EU pricing.</li><li>But Bluebird also said the EMA has requested amendments, which will delay the regional launch until early 2020.</li><li>Bluebird shares are <font color=\"red\">down 5.5%</font> to $117.11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471525\" data-linked=\"Bluebird -5.5% on EU Zynteglo delay\" data-tweet=\"$BLUE - Bluebird -5.5% on EU Zynteglo delay https://seekingalpha.com/news/3471525-bluebirdminus-5_5-on-eu-zynteglo-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3471525-bluebirdminus-5_5-on-eu-zynteglo-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471523\" data-ts=\"1560537148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOCU\" target=\"_blank\">DOCU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471523-docusignplus-4_6-event-displays-growth-prospects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DocuSign +4.6% as event displays growth prospects</a></h4><ul><li>DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) <font color=\"green\">gains 4.6%</font> after the Momentum user conference.</li><li>Morgan Stanley says the event \"showcased core product strength widening the competitive moat\" and management inspired \"confidence in sustainability of forward growth.\"</li><li>The firm maintains an Overweight rating and $61 PT.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471523\" data-linked=\"DocuSign +4.6% as event displays growth prospects\" data-tweet=\"$DOCU - DocuSign +4.6% as event displays growth prospects https://seekingalpha.com/news/3471523-docusignplus-4_6-event-displays-growth-prospects?source=tweet\" data-url=\"https://seekingalpha.com/news/3471523-docusignplus-4_6-event-displays-growth-prospects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471521\" data-ts=\"1560536630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471521-microcaps-dominate-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate tech movers</a></h4><ul><li><strong>Gainers: </strong>Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"green\">+16%</font>. Jiayin Group (NASDAQ:<a href='https://seekingalpha.com/symbol/JFIN' title='Jiayin Group Inc.'>JFIN</a>) <font color=\"green\">+11%</font>. TuanChe (NASDAQ:<a href='https://seekingalpha.com/symbol/TC' title='TuanChe Limited'>TC</a>) <font color=\"green\">+10%</font>. Harmonic (NASDAQ:<a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a>) <font color=\"green\">+8%</font>. Alaska Communications Systems Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ALSK' title='Alaska Communications Systems Group, Inc.'>ALSK</a>) <font color=\"green\">+8%</font>.</li> <li><strong>Losers: </strong>Renren (NYSE:<a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a>) <font color=\"red\">-18%</font>. China Finance Online (NASDAQ:<a href='https://seekingalpha.com/symbol/JRJC' title='China Finance Online Co. Limited'>JRJC</a>) <font color=\"red\">-13%</font>. Eltek (NASDAQ:<a href='https://seekingalpha.com/symbol/ELTK' title='Eltek Ltd.'>ELTK</a>) <font color=\"red\">-12%</font>. RigNet (NASDAQ:<a href='https://seekingalpha.com/symbol/RNET' title='RigNet, Inc.'>RNET</a>) <font color=\"red\">-10%</font>. Everspin Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MRAM' title='Everspin Technologies, Inc.'>MRAM</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471521\" data-linked=\"Microcaps dominate tech movers\" data-tweet=\"$MOXC $JFIN $TC - Microcaps dominate tech movers https://seekingalpha.com/news/3471521-microcaps-dominate-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471521-microcaps-dominate-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471520\" data-ts=\"1560536349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471520-telecom-italia-to-delist-shares-from-nyse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telecom Italia to delist shares from NYSE</a></h4><ul>   <li>Telecom Italia (<a href='https://seekingalpha.com/symbol/TI' title='Telecom Italia S.p.A.'>TI</a> <font color=\"red\">-3.2%</font>, <a href='https://seekingalpha.com/symbol/TI.A' title='Telecom Italia S.p.A.'>TI.A</a> <font color=\"red\">-2.8%</font>) says it will start a voluntary process to <a href=\"https://www.telecomitalia.com/tit/en/archivio/media/comunicati-stampa/telecom-italia/corporate/economico-finanziario/2019/CS-delisting-NYSE.html\" target=\"_blank\">delist its American Depositary Shares from the NYSE</a>.</li>    <li>Both ordinary share ADS and savings share ADS will be delisted.</li>    <li>It's doing that in order to reduce administrative costs and complexity in its financial reporting.</li>    <li>Both level 2 ADR programs will be converted into level 1 ADRs, which would give existing holders the option to keep holding them (level 1 ADRs are traded over the counter).</li>    <li>It expects delisting to occur 10 days after it submits a related Form 25 to the SEC.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471520\" data-linked=\"Telecom Italia to delist shares from NYSE\" data-tweet=\"$TI $TI.A - Telecom Italia to delist shares from NYSE https://seekingalpha.com/news/3471520-telecom-italia-to-delist-shares-from-nyse?source=tweet\" data-url=\"https://seekingalpha.com/news/3471520-telecom-italia-to-delist-shares-from-nyse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471516\" data-ts=\"1560535267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471516-abraxas-petroleum-and-permian-basin-royalty-trust-among-energy-materials-gainers-carbo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abraxas Petroleum and Permian Basin Royalty Trust among Energy/Materials gainers; CARBO Ceramics and Nabors Industries among losers</a></h4><ul><li><b>Gainers: </b>Abraxas Petroleum (NASDAQ:<a href='https://seekingalpha.com/symbol/AXAS' title='Abraxas Petroleum Corporation'>AXAS</a>) <font color=\"green\">+9%</font>. Permian Basin Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/PBT' title='Permian Basin Royalty Trust'>PBT</a>) <font color=\"green\">+6%</font>. Gold Resource (NYSEMKT:<a href='https://seekingalpha.com/symbol/GORO' title='Gold Resource Corporation'>GORO</a>) <font color=\"green\">+6%</font>. Contango Oil &amp; Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"red\">-17%</font>. Nabors Industries (NYSE:<a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a>) <font color=\"red\">-13%</font>. Superior Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a>) <font color=\"red\">-11%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-10%</font>. Diamond Offshore Drilling (NYSE:<a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling, Inc.'>DO</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471516\" data-linked=\"Abraxas Petroleum and Permian Basin Royalty Trust among Energy/Materials gainers; CARBO Ceramics and Nabors Industries among losers\" data-tweet=\"$AXAS $PBT $GORO - Abraxas Petroleum and Permian Basin Royalty Trust among Energy/Materials gainers; CARBO Ceramics and Nabors Industries among losers https://seekingalpha.com/news/3471516-abraxas-petroleum-and-permian-basin-royalty-trust-among-energy-materials-gainers-carbo?source=tweet\" data-url=\"https://seekingalpha.com/news/3471516-abraxas-petroleum-and-permian-basin-royalty-trust-among-energy-materials-gainers-carbo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471601\" data-ts=\"1560535119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471601-transocean-downgraded-citi-amid-rough-ride-for-drilling-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean downgraded at Citi amid rough ride for drilling stocks</a></h4><ul><li>Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-4.4%</font>) tumbles to a new 52-week low after Citi <a href=\"https://thefly.com/thestreet/realmoney/index.php/RIGid2922119/RIG-Transocean-downgraded-to-Neutral-from-Buy-at-Citi\" target=\"_blank\">downgrades</a> shares to Neutral from Buy with a $6.70 price target, slashed from $11.</li><li>Citi analyst Scott Gruber says his organic cash burn analysis implies the drillers will burn cash until \"at least\" 2021, and his base case has floater utilization remains below 70% by 2022, \"well below the level needed to see significant pricing power.\"</li><li>It has been a rough ride lately for the drilling sector, with RIG <font color=\"red\">-11%</font> this week, and peers <a href='https://seekingalpha.com/symbol/ESV' title='Ensco Rowan plc'>ESV</a> <font color=\"red\">-18%</font>, <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color=\"red\">-24%</font>, <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a> <font color=\"red\">-14%</font>, <a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling, Inc.'>DO</a> <font color=\"red\">-11%</font> and <a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color=\"red\">-10%</font> on the week.</li><li>RIG's average <a href=\"https://seekingalpha.com/symbol/RIG/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, while its average <a href=\"https://seekingalpha.com/symbol/RIG/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Neutral and its <a href=\"https://seekingalpha.com/symbol/RIG/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Bearish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471601\" data-linked=\"Transocean downgraded at Citi amid rough ride for drilling stocks\" data-tweet=\"$RIG $ESV $NE - Transocean downgraded at Citi amid rough ride for drilling stocks https://seekingalpha.com/news/3471601-transocean-downgraded-citi-amid-rough-ride-for-drilling-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3471601-transocean-downgraded-citi-amid-rough-ride-for-drilling-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471512\" data-ts=\"1560534211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYGN\" target=\"_blank\">MYGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471512-rough-session-for-myriad-bear-gets-bearish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for Myriad as bear gets more bearish</a></h4><ul><li>Barclays analyst Jack Meehan now sees a 35% chance (vs. 20% previously) that Myriad Genetics' (<a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a> <font color='red'>-7.9%</font>) GeneSight test could lose out on Medicare coverage.</li><li>He trims his price target to $18 from $20. With today's decline, MYGN is trading just below $24. The average sell-side price target is roughly $35, and the <a href=\"https://seekingalpha.com/symbol/MYGN/ratings/sell-side-ratings\" target=\"_blank\">average sell-side rating</a> is Outperform.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471512\" data-linked=\"Rough session for Myriad as bear gets more bearish\" data-tweet=\"$MYGN - Rough session for Myriad as bear gets more bearish https://seekingalpha.com/news/3471512-rough-session-for-myriad-bear-gets-bearish?source=tweet\" data-url=\"https://seekingalpha.com/news/3471512-rough-session-for-myriad-bear-gets-bearish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471506\" data-ts=\"1560532009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEET\" target=\"_blank\">MEET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471506-meet-groupplus-3_8-on-30m-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meet Group +3.8% on $30M buyback</a></h4><ul><li>The Meet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a>) <a href=\"https://seekingalpha.com/pr/17545230-meet-group-announces-new-30-million-share-repurchase-authorization\" target=\"_blank\">announces</a> a $30M share repurchase program that expires at the end of 2021.</li><li>The funding will come from cash from operations.</li><li>MEET shares are <font color=\"green\">up 3.8%</font> to $3.53, paring the earlier losses after short-seller <a href=\"https://friendlybearresearch.com/2019/06/14/meet-group-monetization-of-explicit-live-cam-content-threatens-app-store-revenues/\" target=\"_blank\">The Friendly Bear</a> warned the company's monetization of explicit live cam content threatens its App Store revenues.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471506\" data-linked=\"Meet Group +3.8% on $30M buyback\" data-tweet=\"$MEET - Meet Group +3.8% on $30M buyback https://seekingalpha.com/news/3471506-meet-groupplus-3_8-on-30m-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3471506-meet-groupplus-3_8-on-30m-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471504\" data-ts=\"1560531648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471504-euro-tech-holdings-only-industrial-gainer-barnes-group-and-hudson-technologies-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Euro Tech Holdings only industrial gainer; Barnes Group and Hudson Technologies among losers</a></h4><ul><li><b>Gainers: </b>Euro Tech Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-15%</font>. Hudson Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies Inc.'>HDSN</a>) <font color=\"red\">-12%</font>. Astronics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATRO' title='Astronics Corporation'>ATRO</a>) <font color=\"red\">-8%</font>. Barnes Group (NYSE:<a href='https://seekingalpha.com/symbol/B' title='Barnes Group Inc.'>B</a>) <font color=\"red\">-7%</font>. Spirit AeroSystems (NYSE:<a href='https://seekingalpha.com/symbol/SPR' title='Spirit AeroSystems Holdings, Inc.'>SPR</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471504\" data-linked=\"Euro Tech Holdings only industrial gainer; Barnes Group and Hudson Technologies among losers\" data-tweet=\"$CLWT $CETX $HDSN - Euro Tech Holdings only industrial gainer; Barnes Group and Hudson Technologies among losers https://seekingalpha.com/news/3471504-euro-tech-holdings-only-industrial-gainer-barnes-group-and-hudson-technologies-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471504-euro-tech-holdings-only-industrial-gainer-barnes-group-and-hudson-technologies-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471500\" data-ts=\"1560531458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471500-financials-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers:</b> BBX Capital (NYSE:<a href='https://seekingalpha.com/symbol/BBX' title='BBX Capital Corporation'>BBX</a>) <font color=\"green\">+15%</font>. Dunxin Financial Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/DXF' title='Dunxin Financial Holdings Limited'>DXF</a>) <font color=\"green\">+12%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"green\">+11%</font>. Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) <font color=\"green\">+7%</font>. Ocwen Financial (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Ashford Hospitality Trust (NYSE:<a href='https://seekingalpha.com/symbol/AHT' title='Ashford Hospitality Trust, Inc.'>AHT</a>) <font color=\"red\">-15%</font>. PPDAI Group (NYSE:<a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a>) <font color=\"red\">-10%</font>. China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-8%</font>. Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yirendai Ltd.'>YRD</a>) <font color=\"red\">-7%</font>. Washington Prime Group (NYSE:<a href='https://seekingalpha.com/symbol/WPG' title='Washington Prime Group Inc.'>WPG</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471500\" data-linked=\"Financials - Top 5 Gainers / Losers\" data-tweet=\"$BBX $DXF $PUYI - Financials - Top 5 Gainers / Losers https://seekingalpha.com/news/3471500-financials-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471500-financials-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471499\" data-ts=\"1560530647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471499-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers:</strong> Bluegreen Vacations (NYSE:<a href='https://seekingalpha.com/symbol/BXG' title='Bluegreen Vacations Corporation'>BXG</a>) <font color=\"green\">+35%</font>. ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) <font color=\"green\">+34%</font>. Avadel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) <font color=\"green\">+20%</font>. Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"green\">+17%</font>. Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"green\">+17%</font>. BBX Capital (NYSE:<a href='https://seekingalpha.com/symbol/BBX' title='BBX Capital Corporation'>BBX</a>) <font color=\"green\">+15%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"green\">+11%</font>. MYOS RENS Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology Inc.'>MYOS</a>) <font color=\"green\">+13%</font>. Jiayin Group (NASDAQ:<a href='https://seekingalpha.com/symbol/JFIN' title='Jiayin Group Inc.'>JFIN</a>) <font color=\"green\">+12%</font>. Dunxin Financial Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/DXF' title='Dunxin Financial Holdings Limited'>DXF</a>) <font color=\"green\">+12%</font>.</li> <li><strong>Losers: </strong>Seres Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics, Inc.'>MCRB</a>) <font color=\"red\">-23%</font>. Renren (NYSE:<a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a>) <font color=\"red\">-19%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"red\">-17%</font>. Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-16%</font>. Ashford Hospitality Trust (NYSE:<a href='https://seekingalpha.com/symbol/AHT' title='Ashford Hospitality Trust, Inc.'>AHT</a>) <font color=\"red\">-15%</font>. Performant Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/PFMT' title='Performant Financial Corporation'>PFMT</a>) <font color=\"red\">-14%</font>. Midatech Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/MTP' title='Midatech Pharma Plc'>MTP</a>) <font color=\"red\">-14%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"red\">-12%</font>. ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"red\">-11%</font>. Nabors Industries (NYSE:<a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a>) <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471499\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$BXG $ARQL $AVDL - Microcaps mostly among midday movers https://seekingalpha.com/news/3471499-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471499-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471498\" data-ts=\"1560530412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UGLD\" target=\"_blank\">UGLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471498-gundlach-bets-on-gold-recession-risk-rises\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gundlach bets on gold, as recession risk rises</a></h4><ul><li>DoubleLine CEO Jeffrey Gundlach, also known as the \"bond king\", sees a 40%-45% chance of recession in the next six months rising to 65% change in the next 12 months, he told investors on a webcast after Thursday's close.</li><li>He's long on gold, on the basis that he sees the dollar ending the year lower.</li><li>Gold <font color=\"green\">rises 0.6%</font> to $1,351.50 per ounce; VelocityShares 3x Long Gold ETN (<a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a> <font color='green'>+1.5%</font>).</li><li>Several indicators are flashing red; specifically the spread between consumer confidence expectations and current conditions is near an all-time low.</li><li>As he as in the past, Gundlach warns that the \"soaring\" U.S. deficit could get much worse in the next recession.</li><li>Gold ETFs: <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/IAUF' title='iShares Gold Strategy ETF'>OTC:IAUF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3471498\" data-linked=\"Gundlach bets on gold, as recession risk rises\" data-tweet=\"$UGLD $UGL $DGP - Gundlach bets on gold, as recession risk rises https://seekingalpha.com/news/3471498-gundlach-bets-on-gold-recession-risk-rises?source=tweet\" data-url=\"https://seekingalpha.com/news/3471498-gundlach-bets-on-gold-recession-risk-rises\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471496\" data-ts=\"1560530015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSB\" target=\"_blank\">OSB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471496-norbord-upgraded-bmo-on-idling-of-oriented-strand-board-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Norbord upgraded at BMO on idling of oriented strand board production</a></h4><ul><li>Norbord (<a href='https://seekingalpha.com/symbol/OSB' title='Norbord Inc.'>OSB</a> <font color='green'>+7.1%</font>) shoots higher after BMO Capital <a href=\"https://thefly.com/thestreet/realmoney/index.php/OSB;LPXid2922028/OSB;LPX-Norbord-upgraded-to-Outperform-from-Market-Perform-at-BMO-Capital\" target=\"_blank\">upgrades</a> shares to Outperform from Market Perform with a $28 price target, up from $26, citing announcements from the company and Louisiana-Pacific (<a href='https://seekingalpha.com/symbol/LPX' title='Louisiana-Pacific Corporation'>LPX</a> <font color='green'>+3.2%</font>) to indefinitely idle oriented strand board mills that remove 5% of industry capacity.</li><li>BMO analyst Ketan Mamtora believes the reduced production should alleviate supply overhang and aid Norbord's pricing.</li><li>OSB's valuation now looks \"very attractive,\" its balance sheet is \"healthy,\" and the company has made \"solid progress\" in improving European performance, Mamtora says, adding that the stock's \"risks are skewed clearly to the upside.\"</li><li>OSB's average <a href=\"https://seekingalpha.com/symbol/OSB/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, while the stock's <a href=\"https://seekingalpha.com/symbol/OSB/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Bearish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471496\" data-linked=\"Norbord upgraded at BMO on idling of oriented strand board production\" data-tweet=\"$OSB $LPX - Norbord upgraded at BMO on idling of oriented strand board production https://seekingalpha.com/news/3471496-norbord-upgraded-bmo-on-idling-of-oriented-strand-board-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3471496-norbord-upgraded-bmo-on-idling-of-oriented-strand-board-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471486\" data-ts=\"1560528133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471486-beyond-meat-leads-consumer-gainers-vector-group-and-tenneco-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat leads consumer gainers; Vector Group and Tenneco among losers</a></h4><ul><li><b>Gainers: </b>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) <font color=\"green\">+6%</font>. Vince Holding (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Tuniu (NASDAQ:<a href='https://seekingalpha.com/symbol/TOUR' title='Tuniu Corporation'>TOUR</a>) <font color=\"red\">-11%</font>. Tenneco (NYSE:<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) <font color=\"red\">-7%</font>. Vector Group (NYSE:<a href='https://seekingalpha.com/symbol/VGR' title='Vector Group Ltd.'>VGR</a>) <font color=\"red\">-6%</font>. Hooker Furniture (NASDAQ:<a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471486\" data-linked=\"Beyond Meat leads consumer gainers; Vector Group and Tenneco among losers\" data-tweet=\"$BYND $VNCE $TOUR - Beyond Meat leads consumer gainers; Vector Group and Tenneco among losers https://seekingalpha.com/news/3471486-beyond-meat-leads-consumer-gainers-vector-group-and-tenneco-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471486-beyond-meat-leads-consumer-gainers-vector-group-and-tenneco-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471483\" data-ts=\"1560527545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471483-fastenal-slides-after-buckingham-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal slides after Buckingham warning</a></h4><ul> <li>Fastenal (NASDAQ:<a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a>) <font color=\"red\">sheds 4.22%</font> after Buckingham Research <a href=\"https://twitter.com/BuckResearch\" target=\"_blank\">lowers</a> estimates on concerns of faltering sales trends and and margin pressure amid rising headcount.</li> <li>Buckingham expects 2019 EPS of 1.41 vs. $1.42 consensus and $1.44 prior view. 2020 EPS of $1.51 is anticipated vs. $1.53 consensus and $1.54 prior view.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3471483\" data-linked=\"Fastenal slides after Buckingham warning\" data-tweet=\"$FAST - Fastenal slides after Buckingham warning https://seekingalpha.com/news/3471483-fastenal-slides-after-buckingham-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3471483-fastenal-slides-after-buckingham-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471482\" data-ts=\"1560527111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUM\" target=\"_blank\">SUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471482-analysts-differ-on-value-legitimacy-of-summit-materials-merger-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts differ on value, legitimacy of Summit Materials merger talk</a></h4><ul><li>Summit Materials (<a href='https://seekingalpha.com/symbol/SUM' title='Summit Materials, Inc.'>SUM</a> <font color=\"red\">-3.3%</font>) surrenders some of yesterday's 14% gain sparked by a report that Colombia's Cementos Argos has approached the company about a <a href=\"https://seekingalpha.com/news/3471135-colombian-firm-approaches-summit-materials-merger-reuters\" target=\"_blank\">possible merger</a>.</li><li>Stifel analyst Stanley Elliott thinks SUM is meaningfully undervalued even after yesterday's move but says he is not sure the sources of the merger reports are credible.</li><li>\"<a href=\"https://thefly.com/thestreet/realmoney/index.php/SUMid2922132/SUM-Summit-merger-report-feels-like-a-rumor-but-upside-remains-says-Stifel\" target=\"_blank\">This feels like a rumor</a>\" as a way to shift the discussion from challenges the company currently faces, Elliott says, keeping a Buy rating and $23 price target on the shares.</li><li>But Barclays analyst Adam Seiden believes Argos' interest is \"<a href=\"https://thefly.com/thestreet/realmoney/index.php/SUMid2922075/SUM-Summit-Materials-takeover-interest-likely-genuine-says-Barclays\" target=\"_blank\">likely genuine</a>\" as a small player in the U.S. market but that generates half of its EBITDA in the U.S. and its other regions are either just starting to recover; he rates SUM at Equal Weight with an $18 target.</li><li>Deutsche Bank's Nishu Sood says the combined company would become substantially larger in cement and ready-mix, but <a href=\"https://thefly.com/thestreet/realmoney/index.php/SUMid2922143/SUM-Argos-Summit-Materials-operating-synergies-may-be-limited-says-Deutsche-Bank\" target=\"_blank\">operating synergies might be limited</a> and would carry a lot of debt.</li><li>SUM's average <a href=\"https://seekingalpha.com/symbol/SUM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, its average <a href=\"https://seekingalpha.com/symbol/SUM/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Bearish, and its <a href=\"https://seekingalpha.com/symbol/SUM/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471482\" data-linked=\"Analysts differ on value, legitimacy of Summit Materials merger talk\" data-tweet=\"$SUM - Analysts differ on value, legitimacy of Summit Materials merger talk https://seekingalpha.com/news/3471482-analysts-differ-on-value-legitimacy-of-summit-materials-merger-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3471482-analysts-differ-on-value-legitimacy-of-summit-materials-merger-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471475\" data-ts=\"1560525290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPR\" target=\"_blank\">SPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471475-commercial-aerospace-stocks-cut-suntrust\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commercial aerospace stocks cut at SunTrust</a></h4><ul><li>Spirit AeroSystems (<a href='https://seekingalpha.com/symbol/SPR' title='Spirit AeroSystems Holdings, Inc.'>SPR</a> <font color='red'>-4.9%</font>), Astronics (<a href='https://seekingalpha.com/symbol/ATRO' title='Astronics Corporation'>ATRO</a> <font color='red'>-6%</font>) and Barnes Group (<a href='https://seekingalpha.com/symbol/B' title='Barnes Group Inc.'>B</a> <font color='red'>-6.1%</font>) are all sharply lower after SunTrust RH <a href=\"https://www.marketwatch.com/story/commercial-aerospace-stocks-fall-after-suntrust-turns-bearish-citing-unprecedented-737-max-unknowns-2019-06-14\" target=\"_blank\">downgrades shares to Sell</a> from Hold, citing ongoing uncertainties related to the grounding of Boeing's 737 MAX jets.</li><li>Woodward (<a href='https://seekingalpha.com/symbol/WWD' title='Woodward, Inc.'>WWD</a> <font color='red'>-2.6%</font>) and Ducommun (<a href='https://seekingalpha.com/symbol/DCO' title='Ducommun Incorporated'>DCO</a> <font color='red'>-5.5%</font>) also are lower after the firm downgrades shares to Hold from Buy.</li><li>\"Given the current industry unknowns tied to 737, and our expectation that 2019-20 outlooks and Street estimates need to be lowered, we cannot continue to advise investors to buy, or in some cases, own names in our coverage universe during this uncertain and unprecedented time,\" analyst Mike Ciarmoli writes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471475\" data-linked=\"Commercial aerospace stocks cut at SunTrust\" data-tweet=\"$SPR $ATRO $B - Commercial aerospace stocks cut at SunTrust https://seekingalpha.com/news/3471475-commercial-aerospace-stocks-cut-suntrust?source=tweet\" data-url=\"https://seekingalpha.com/news/3471475-commercial-aerospace-stocks-cut-suntrust\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471472\" data-ts=\"1560524439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471472-barnes-nobleminus-3-after-keep-shop-period-expires-no-new-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble -3% after &#39;keep-shop&#39; period expires with no new offer</a></h4><ul> <li>Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble, Inc.'>BKS</a> <font color=\"red\">-2.6%</font>) falls after Publisher's Weekly tips that the company received no new bids during the \"keep-shop\" period on the Elliott Management deal.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3471472\" data-linked=\"Barnes &amp; Noble -3% after &#39;keep-shop&#39; period expires with no new offer\" data-tweet=\"$BKS - Barnes &amp; Noble -3% after &#39;keep-shop&#39; period expires with no new offer https://seekingalpha.com/news/3471472-barnes-nobleminus-3-after-keep-shop-period-expires-no-new-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3471472-barnes-nobleminus-3-after-keep-shop-period-expires-no-new-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471471\" data-ts=\"1560524429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471471-arqule-leads-healthcare-gainers-seres-therapeutics-and-midatech-pharma-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArQule leads healthcare gainers; Seres Therapeutics and Midatech Pharma among losers</a></h4><ul><li><b>Gainers: </b>ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) <font color=\"green\">+39%</font>. Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"green\">+23%</font>. Avadel Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVDL' title='Avadel Pharmaceuticals plc'>AVDL</a>) <font color=\"green\">+20%</font>. Fennec Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/FENC' title='Fennec Pharmaceuticals Inc.'>FENC</a>) <font color=\"green\">+11%</font>. Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Seres Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics, Inc.'>MCRB</a>) <font color=\"red\">-24%</font>. ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"red\">-12%</font>. Midatech Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/MTP' title='Midatech Pharma Plc'>MTP</a>) <font color=\"red\">-11%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"red\">-8%</font>. Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471471\" data-linked=\"ArQule leads healthcare gainers; Seres Therapeutics and Midatech Pharma among losers\" data-tweet=\"$ARQL $OTLK $AVDL - ArQule leads healthcare gainers; Seres Therapeutics and Midatech Pharma among losers https://seekingalpha.com/news/3471471-arqule-leads-healthcare-gainers-seres-therapeutics-and-midatech-pharma-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471471-arqule-leads-healthcare-gainers-seres-therapeutics-and-midatech-pharma-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471467\" data-ts=\"1560523933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHT\" target=\"_blank\">AHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471467-ashford-hospitality-sinks-15-after-cutting-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ashford Hospitality sinks 15% after cutting dividend</a></h4><ul><li>Ashford Hospitality Trust (NYSE:<a href='https://seekingalpha.com/symbol/AHT' title='Ashford Hospitality Trust, Inc.'>AHT</a>) <font color=\"red\">slumps 15% </font>after the REIT slashes its <a href=\"https://seekingalpha.com/news/3471363-ashford-hospitality-trust-declares-0_06-dividend\" target=\"_blank\">quarterly dividend</a> by half.</li><li>\"This adjustment effectively <a href=\"https://seekingalpha.com/pr/17544877-ashford-trust-declares-dividends-second-quarter-2019\" target=\"_blank\">preserves capital </a>for more advantageous purposes including strengthening our balance sheet and enhancing our ability to pursue more opportunistic growth such as acquisitions that qualify for our Enhanced Return Funding Program,\" said AHT President and CEO Douglas A. Kessler.</li><li>AHT also reports certain operating metrics on four ERFP investments.</li></ul><ol><li>Embassy Suites New York Midtown Manhattan RevPAR has increased 35% YTD, significantly exceeding underwritten growth for the first year.</li><li>La Posada de Santa Fe YTD hotel EBITDA increased 182% over the year-ago period and YTD RevPAR increased 16%.</li><li>Hilton Alexandria Old Town group revenue pace for Q3 and Q4 of 209 is up 24% than prior year; property has achieved positive gross operating profit flow-through in eight of the 10 months since acquisition.</li><li>Hilton Santa Cruz/Scotts Valley is achieving TTM RevPAR index gains, while TTM NOI and NOI margins are approaching first year underwritten projections.</li></ol><div class=\"tiny-share-widget\" data-id=\"3471467\" data-linked=\"Ashford Hospitality sinks 15% after cutting dividend\" data-tweet=\"$AHT - Ashford Hospitality sinks 15% after cutting dividend https://seekingalpha.com/news/3471467-ashford-hospitality-sinks-15-after-cutting-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3471467-ashford-hospitality-sinks-15-after-cutting-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471462\" data-ts=\"1560523217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTR\" target=\"_blank\">VTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471462-ventasplus-1_8-analyst-is-bullish-on-colony-capital-refinancing-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ventas +1.8% as analyst is bullish on Colony Capital refinancing deal</a></h4><ul><li>Ventas (NYSE:<a href='https://seekingalpha.com/symbol/VTR' title='Ventas, Inc.'>VTR</a>) <font color=\"green\">advances 1.8%</font> after announcing post-market Thursday an agreement to provide $490M of financing to Colony Capital (NYSE:<a href='https://seekingalpha.com/symbol/CLNY' title='Colony Capital, Inc.'>CLNY</a>) as part of Colony's refinancing of a health-care loan.</li><li>The deal could give Ventas an \"inside track\" to own the investments if Colony decides to exit health care, writes Capital One analyst Daniel Bernstein.</li><li>It's also provides an indirect way for Ventas to invest in skilled nursing, with about one-third of Colony's health-care NOI comes from skilled nursing, he writes.</li><li>Reiterates overweight recommendation and $69 price target for Ventas.</li><li><a href=\"https://seekingalpha.com/symbol/VTR/ratings/sell-side-ratings\" target=\"_blank\">Sell-side average rating</a> Neutral (2 Buy, 17 Hold, 2 Sell), average price target $63.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471462\" data-linked=\"Ventas +1.8% as analyst is bullish on Colony Capital refinancing deal\" data-tweet=\"$VTR $CLNY - Ventas +1.8% as analyst is bullish on Colony Capital refinancing deal https://seekingalpha.com/news/3471462-ventasplus-1_8-analyst-is-bullish-on-colony-capital-refinancing-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3471462-ventasplus-1_8-analyst-is-bullish-on-colony-capital-refinancing-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471461\" data-ts=\"1560522887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHN\" target=\"_blank\">SCHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471461-schnitzer-announces-preliminary-q319-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schnitzer announces preliminary Q319 results</a></h4><ul><li>Schnitzer Steel (<a href='https://seekingalpha.com/symbol/SCHN' title='Schnitzer Steel Industries, Inc.'>SCHN</a> <font color='green'>+1.7%</font>) <a href=\"https://seekingalpha.com/pr/17544855-schnitzer-announces-third-quarter-fiscal-2019-preliminary-results-earnings-date\" target=\"_blank\">expects</a> Q3 Adj. EPS in the range of $0.58 - 0.62 vs a consensus of $0.58.</li><li>Q3 operating cash flow in the range of $32M - $37M.</li><li>Total debt was $142M (end of Q3) and debt, net of cash, was $134M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471461\" data-linked=\"Schnitzer announces preliminary Q319 results\" data-tweet=\"$SCHN - Schnitzer announces preliminary Q319 results https://seekingalpha.com/news/3471461-schnitzer-announces-preliminary-q319-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3471461-schnitzer-announces-preliminary-q319-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471459\" data-ts=\"1560522819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471459-global-blood-sickle-cell-drug-data-passes-sharesminus-3_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Blood sickle cell drug data passes; shares -3.7%</a></h4><ul>   <li>Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics, Inc.'>GBT</a>) is <font color=\"red\">3.7% lower</font> after posting data in the <i>New England Journal of Medicine</i> showing its <a href=\"https://seekingalpha.com/pr/17544718-gbt-announces-updated-24-week-efficacy-data-patients-enrolled-phase-3-hope-study-showing\" target=\"_blank\">sickle cell disease drug met primary endpoints</a>.</li>    <li>Data came from its Phase 3 HOPE study of voxelotor in patients 12 and older (about 274 adolescents and adults).</li>    <li>The study showed an improvement in hemoglobin greater than 1 g/dL at 24 weeks with voxelotor 1500 mg compared with placebo, along with a favorable safety and tolerability profile.</li>    <li>Some analysts are concerned, though, that the results might not translate to better health outcomes.</li>    <li>The data prompted Cantor Fitzgerald to boost its price target to $110 from $96; that now implies 98% upside after today's decline.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471459\" data-linked=\"Global Blood sickle cell drug data passes; shares -3.7%\" data-tweet=\"$GBT - Global Blood sickle cell drug data passes; shares -3.7% https://seekingalpha.com/news/3471459-global-blood-sickle-cell-drug-data-passes-sharesminus-3_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3471459-global-blood-sickle-cell-drug-data-passes-sharesminus-3_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471453\" data-ts=\"1560522174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCM\" target=\"_blank\">CMCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471453-cheetah-mobileminus-3-profits-lag-despite-solid-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheetah Mobile -3% as profits lag despite solid revenues</a></h4><ul>   <li>Cheetah Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>) is <font color=\"red\">3% lower</font> today coming out of a miss on profit expectations from its Q1 earnings.</li>    <li>Revenues topped high estimates after only declining 5.2%, to 1.09B yuan (about $161.8M).</li>    <li>Gross profit was 718.7M yuan (about $107.1M), with stable gross margin at 66.2%.</li>    <li>Earnings per ADR fell to 0.17 yuan -- or about $0.03 from $0.08, though, and EBITDA fell 85% to 25.3M yuan (about $3.8M).</li>    <li>Global mobile monthly active users was 434.8M; overseas markets made up 70.3% of the total.</li>    <li>Liquidity including restricted cash and short-term investments was 3.42B yuan (about $510M).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3471368-cheetah-mobile-eps-misses-rmb0_16-beats-revenue\" target=\"_blank\">Cheetah Mobile EPS misses by RMB0.16, beats on revenue</a> (Jun. 14 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17544851-cheetah-mobile-announces-first-quarter-2019-unaudited-consolidated-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3471453\" data-linked=\"Cheetah Mobile -3% as profits lag despite solid revenues\" data-tweet=\"$CMCM - Cheetah Mobile -3% as profits lag despite solid revenues https://seekingalpha.com/news/3471453-cheetah-mobileminus-3-profits-lag-despite-solid-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3471453-cheetah-mobileminus-3-profits-lag-despite-solid-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471445\" data-ts=\"1560521125\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471445-abercrombie-fitch-approves-new-share-repurchase-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp; Fitch approves new share repurchase program</a></h4><ul><li>Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch Co.'>ANF</a> <font color='green'>+1.2%</font>) board <a href=\"https://seekingalpha.com/pr/17544939-abercrombie-and-fitch-co-announces-authorization-new-share-repurchase-program\" target=\"_blank\">authorizes</a> new share repurchase program of up to 5M shares of Class A Common Stock.</li><li>This brings the shares available for purchase, as of June 12, 2019 under the company's publicly announced share repurchase authorizations, to ~7.6M shares, or over 10% of its total shares outstanding.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471445\" data-linked=\"Abercrombie &amp; Fitch approves new share repurchase program\" data-tweet=\"$ANF - Abercrombie &amp; Fitch approves new share repurchase program https://seekingalpha.com/news/3471445-abercrombie-fitch-approves-new-share-repurchase-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3471445-abercrombie-fitch-approves-new-share-repurchase-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471439\" data-ts=\"1560520514\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FFIV\" target=\"_blank\">FFIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471439-f5minus-6_3-vmware-avi-deal-expected-to-hit-adc-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">F5 -6.3% as VMware/Avi deal expected to hit ADC business</a></h4><ul>   <li>F5 Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a>) is <font color=\"red\">6.2% lower</font> today amid analyst worries about competition from VMware's acquisition of Avi Networks.</li>    <li>Piper Jaffray and William Blair are expressing concerns for F5 that a VMware/Avi combination creates a new application delivery controller product with strong backing.</li>    <li>ADCs are F5's core business; William Blair calls the deal a \"clear negative\" for the company.</li>    <li>VMware will offer an advanced, stand-alone ADC after <a href=\"https://seekingalpha.com/news/3471271-vmware-acquires-avi-networks\" target=\"_blank\">completion of its Avi deal</a>, which is expected to close in 2020's fiscal Q2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471439\" data-linked=\"F5 -6.3% as VMware/Avi deal expected to hit ADC business\" data-tweet=\"$FFIV - F5 -6.3% as VMware/Avi deal expected to hit ADC business https://seekingalpha.com/news/3471439-f5minus-6_3-vmware-avi-deal-expected-to-hit-adc-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3471439-f5minus-6_3-vmware-avi-deal-expected-to-hit-adc-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471422\" data-ts=\"1560518979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENTA\" target=\"_blank\">ENTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471422-enata-pharmaplus-6_8-study-shows-drug-cuts-symptons-in-viral-lung-infection\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enata Pharma +6.8% as study shows drug cuts symptons in viral lung infection</a></h4><ul>    <li>Enata Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a>) is <font color=\"green\">up 6.8%</font> premarket after the company notes EDP-938 <a href=\"https://seekingalpha.com/pr/17544769-enanta-pharmaceuticals-announces-topline-results-showing-edpminus-938-achieved-primary\" target=\"_blank\">cut the amount of virus detected</a> in the body in a study of healthy adults infected with respiratory syncytial virus.</li><li>It also resolved symptoms better than placebo.</li>    <li>The drug achieved its primary and secondary endpoints in the phase 2a human challenge study.</li><li>\u201cBased on today\u2019s positive data for EDP-938, the only       N-inhibitor in clinical development, our goal is to initiate our first       Phase 2b study by the end of calendar 2019 in adult outpatients with       confirmed RSV infections,\" says CEO Jay Luly.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471422\" data-linked=\"Enata Pharma +6.8% as study shows drug cuts symptons in viral lung infection\" data-tweet=\"$ENTA - Enata Pharma +6.8% as study shows drug cuts symptons in viral lung infection https://seekingalpha.com/news/3471422-enata-pharmaplus-6_8-study-shows-drug-cuts-symptons-in-viral-lung-infection?source=tweet\" data-url=\"https://seekingalpha.com/news/3471422-enata-pharmaplus-6_8-study-shows-drug-cuts-symptons-in-viral-lung-infection\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471416\" data-ts=\"1560518406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471416-bitcoin-near-ytd-high-crypto-fans-mull-facebooks-entry\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin near YTD high as crypto fans mull Facebook&#39;s entry</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3471296-visa-mastercard-paypal-uber-board-facebook-cryptocurrency-wsj\" target=\"_blank\">Facebook's \"Project Libra\" continues </a>to move along, with some reports tipping the unveiling of the FB cryptocurrency as soon as next week. Last night, the <em>WSJ </em>reported more than a dozen companies - including Visa, Mastercard, PayPal, and Uber - had signed up in support.</li><li><a href=\"https://twitter.com/barrysilbert/status/1139515995209502721\" target=\"_blank\">Barry Silbert captures the mood</a> for at least some crypto fans, calling it \"THE catalyst that propelled digital assets to mass global consumer adoption.\"</li><li>Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) continues its strong move this week, now just shy of $8.4K.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471416\" data-linked=\"Bitcoin near YTD high as crypto fans mull Facebook&#39;s entry\" data-tweet=\"$GBTC $BTC-USD - Bitcoin near YTD high as crypto fans mull Facebook&#39;s entry https://seekingalpha.com/news/3471416-bitcoin-near-ytd-high-crypto-fans-mull-facebooks-entry?source=tweet\" data-url=\"https://seekingalpha.com/news/3471416-bitcoin-near-ytd-high-crypto-fans-mull-facebooks-entry\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471413\" data-ts=\"1560518270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLIT\" target=\"_blank\">HLIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471413-harmonicplus-4_9-raymond-james-raises-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmonic +4.9% as Raymond James raises to Outperform</a></h4><ul>   <li>Harmonic (NASDAQ:<a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a>) is <font color=\"green\">up 4.9%</font> premarket after an upgrade to Outperform at Raymond James, from Market Perform.</li>    <li>The firm set an above-average price target of $6.75, implying 32% upside.</li>    <li>While sell-siders overall <a href=\"https://seekingalpha.com/symbol/HLIT/ratings/sell-side-ratings\" target=\"_blank\">rate the stock an Outperform</a>, it has a <a href=\"https://seekingalpha.com/symbol/HLIT/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Bearish</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471413\" data-linked=\"Harmonic +4.9% as Raymond James raises to Outperform\" data-tweet=\"$HLIT - Harmonic +4.9% as Raymond James raises to Outperform https://seekingalpha.com/news/3471413-harmonicplus-4_9-raymond-james-raises-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3471413-harmonicplus-4_9-raymond-james-raises-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471408\" data-ts=\"1560517769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471408-thin-ranks-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thin ranks among premarket losers</a></h4><ul><li>Seres Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MCRB' title='Seres Therapeutics, Inc.'>MCRB</a>) <font color=\"red\">-22%</font> on <a href=\"https://seekingalpha.com/news/3471309-seres-therapeutics-prices-stock-offering\" target=\"_blank\">pricing stock offering</a>.</li><li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Inc.'>AVGO</a>) <font color=\"red\">-8%</font> as it cautions about <a href=\"https://seekingalpha.com/news/3471252-broadcom-minus-7_3-percent-cautions-slowdown-ahead\" target=\"_blank\">slowdown ahead</a>.</li><li>WhiteHorse Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/WHF' title='WhiteHorse Finance'>WHF</a>) <font color=\"red\">-5%</font> on <a href=\"https://seekingalpha.com/news/3471280-whitehorse-stockholders-sell-shares-secondary-offering\" target=\"_blank\">secondary offering</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471408\" data-linked=\"Thin ranks among premarket losers\" data-tweet=\"$MCRB $AVGO $WHF - Thin ranks among premarket losers https://seekingalpha.com/news/3471408-thin-ranks-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471408-thin-ranks-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471407\" data-ts=\"1560517577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGLY\" target=\"_blank\">DGLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471407-thin-ranks-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thin ranks among premarket gainers</a></h4><ul><li>ArQule ARQL <font color=\"green\">+46%</font> after <a href=\"https://seekingalpha.com/news/3471348-arqule-rallies-reporting-blood-cancer-results\" target=\"_blank\">reporting</a> blood cancer results.</li><li>Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) <font color=\"green\">+8%</font> on multi-year <a href=\"https://seekingalpha.com/pr/17544944-digital-ally-enters-multi-year-agreement-kansas-city-chiefs\" target=\"_blank\">agreement</a> with the Kansas City Chiefs Football Club.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471407\" data-linked=\"Thin ranks among premarket gainers\" data-tweet=\"$DGLY - Thin ranks among premarket gainers https://seekingalpha.com/news/3471407-thin-ranks-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3471407-thin-ranks-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471387\" data-ts=\"1560516268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471387-comcast-gets-new-bull-rosenblatt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast gets a new bull at Rosenblatt</a></h4><ul><li>Rosenblatt starts Comcast (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) at Buy with a $50 price target.</li><li>The firm cites CMCSA's ability to expand its broadband market share over the next five years and notes that the company has been adding subscribers by benefiting from end market growth and taking share from DSL operators.\"</li><li>CMCSA shares are flat pre-market at $41.69.</li><li>Comcast has a Very Bullish <a href=\"https://seekingalpha.com/symbol/CMCSA/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471387\" data-linked=\"Comcast gets a new bull at Rosenblatt\" data-tweet=\"$CMCSA - Comcast gets a new bull at Rosenblatt https://seekingalpha.com/news/3471387-comcast-gets-new-bull-rosenblatt?source=tweet\" data-url=\"https://seekingalpha.com/news/3471387-comcast-gets-new-bull-rosenblatt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471379\" data-ts=\"1560515546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471379-canopy-growth-eyes-u-s-market-through-acreage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy Growth eyes U.S. market through Acreage</a></h4><ul> <li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) says the deal to acquire Acreage represents a clear path for the company to enter the U.S. cannabis market when it becomes legal on a federal level.</li><li>Canopy hopes to leverage Acreage's presence to introduce its brands and consumer products in the U.S.</li><li>Management from both firms see greater shareholder value by teaming up in the U.S.</li><li>A Canopy Growth shareholder vote on the deal is scheduled for June 17.</li>  <li>CGC  <font color=\"red\">-1.48%</font> premarket to  $41.24.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17544887-canopy-growth-acreage-holdings-remind-shareholders-vote-canopy-growths-plan-acquire-acreage\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3471379\" data-linked=\"Canopy Growth eyes U.S. market through Acreage\" data-tweet=\"$CGC $ACRGF $CGC - Canopy Growth eyes U.S. market through Acreage https://seekingalpha.com/news/3471379-canopy-growth-eyes-u-s-market-through-acreage?source=tweet\" data-url=\"https://seekingalpha.com/news/3471379-canopy-growth-eyes-u-s-market-through-acreage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471375\" data-ts=\"1560515234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471375-roan-resources-edges-q2-production-guidance-higher-capex-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roan Resources edges Q2 production guidance higher, capex lower</a></h4><ul><li>Roan Resources (NYSE:<a href='https://seekingalpha.com/symbol/ROAN' title='Roan Resources, Inc.'>ROAN</a>) <a href=\"https://seekingalpha.com/pr/17544872-roan-resources-inc-provides-positive-update-2q-19-guidance-provides-operational-update\" target=\"_blank\">slightly raises its guidance for Q2 production</a> to exceed 50K boe/day from 49K boe/day previously, with plans to turn 14 gross operated wells to first sales during June and July.</li><li>ROAN also forecasts Q2 capex to come in ~10% below original guidance of $155M, saying drilling and completion costs continue to trend lower.</li><li>The company is looking for positive news after plunging 41% so far this week, but shares <font color=\"red\">-7.7%</font> pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471375\" data-linked=\"Roan Resources edges Q2 production guidance higher, capex lower\" data-tweet=\"$ROAN - Roan Resources edges Q2 production guidance higher, capex lower https://seekingalpha.com/news/3471375-roan-resources-edges-q2-production-guidance-higher-capex-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3471375-roan-resources-edges-q2-production-guidance-higher-capex-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471372\" data-ts=\"1560515087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471372-impossible-foods-struggles-to-keep-up-demand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Impossible Foods struggles to keep up with demand</a></h4><ul> <li>Restaurant chains Red Robin Gourmet Burgers (NASDAQ:<a href='https://seekingalpha.com/symbol/RRGB' title='Red Robin Gourmet Burgers, Inc.'>RRGB</a>) and White Castle are seeing <a href=\"https://www.ibj.com/articles/74205-impossible-burger-shortages-hit-white-castle-red-robin\" target=\"_blank\">broad shortages</a> of meat-free patties from Impossible Foods (IMPSBL), according to Bloomberg.</li> <li>The ongoing shortages are said to show the pressure that Impossible Foods is facing to manufacture for the mass market and get a head start on wide distribution before larger companies jump in.</li> <li>Impossible Foods estimates that its already on the menu at 9K restaurants and is expected to roll out nationally at Burger King locations this year.</li> <li>Within the alternative protein sector, shares of Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) are <font color=\"red\">down 0.26%</font> in premarket trading to $141.02 as Tyson's announcement yesterday of a meatless brand not doing too much to rattle investors.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471372\" data-linked=\"Impossible Foods struggles to keep up with demand\" data-tweet=\"$RRGB $BYND - Impossible Foods struggles to keep up with demand https://seekingalpha.com/news/3471372-impossible-foods-struggles-to-keep-up-demand?source=tweet\" data-url=\"https://seekingalpha.com/news/3471372-impossible-foods-struggles-to-keep-up-demand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471367\" data-ts=\"1560514319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCM\" target=\"_blank\">CMCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471367-cheetah-mobileplus-2_8-on-mixed-q1-downside-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheetah Mobile +2.8% on mixed Q1, downside view</a></h4><ul><li>Cheetah Mobile (NYSE:<a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a>) <font color=\"green\">+2.8% </font>reports Q1 results that beat revenue estimates but featured weak adjusted EBITDA of $3.77M, below the $9.96M consensus and down 86% Y/Y.</li><li>Revenue breakdown: Mobile entertainment, RMB556.2M (+42% Y/Y); Other, RMB31.5M (+299%).</li><li>Mobile MAUs totaled $434.8M. Mobile MAUs outside of China accounted for 70% of the total.</li><li>Downside Q2 guidance has revenue of RMB920-950M versus the RMB1.13B estimate from a single analyst.</li><li>Earnings call starts at 8 AM ET with a webcast <a href=\"http://ir.cmcm.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17544851-cheetah-mobile-announces-first-quarter-2019-unaudited-consolidated-financial-results\" target=\"_blank\">Press release</a>.</li><li>Posted updated to correct price data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471367\" data-linked=\"Cheetah Mobile +2.8% on mixed Q1, downside view\" data-tweet=\"$CMCM - Cheetah Mobile +2.8% on mixed Q1, downside view https://seekingalpha.com/news/3471367-cheetah-mobileplus-2_8-on-mixed-q1-downside-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3471367-cheetah-mobileplus-2_8-on-mixed-q1-downside-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471365\" data-ts=\"1560513753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KURA\" target=\"_blank\">KURA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471365-kura-oncology-says-lymphoma-treatment-trial-met-primary-endpoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kura Oncology says lymphoma treatment trial met primary endpoint</a></h4><ul><li>Kura Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology, Inc.'>KURA</a>) <font color=\"green\">+7.9%</font> pre-market after announcing data from a <a href=\"https://seekingalpha.com/pr/17544828-kura-oncology-announces-positive-phase-2-trial-tipifarnib-peripheral-t-cell-lymphoma\" target=\"_blank\">phase 2 clinical trial</a> of its tipifarnib drug candidate in patients with relapsed or refractory peripheral T-cell lymphoma.</li><li>Kura says the results of the trial showed \"ongoing anti-tumor activity and a manageable safety profile\" in advanced patients with angioimmunoblastic T-cell lymphoma, as well as non-AITL relapsed or refractory peripheral T-cell lymphoma.</li><li>The company believes the data support the potential to register tipifarnib in both the AITL and PTCL-NOS patient populations, and plans to seek regulatory feedback on next steps for the program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471365\" data-linked=\"Kura Oncology says lymphoma treatment trial met primary endpoint\" data-tweet=\"$KURA - Kura Oncology says lymphoma treatment trial met primary endpoint https://seekingalpha.com/news/3471365-kura-oncology-says-lymphoma-treatment-trial-met-primary-endpoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3471365-kura-oncology-says-lymphoma-treatment-trial-met-primary-endpoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471355\" data-ts=\"1560513093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COMM\" target=\"_blank\">COMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471355-raymond-james-less-bullish-on-commscope-commminus-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James less bullish on CommScope; COMM -1%</a></h4><ul><li>Raymond James downgrades CommScope (NASDAQ:<a href='https://seekingalpha.com/symbol/COMM' title='CommScope Holding Company, Inc.'>COMM</a>) from Strong Buy to Outperform and lowers the target from $25 to $21.</li><li>The firm cites expectations that the Arris acquisition will \"perform worse than once expected,\" the \"poor\" Q1 results, and the lack of catalysts until maybe Q3.</li><li>But Raymond expects \"strong cash generation, de-levering, and favorable trends in other segments.\"</li><li>CommScope shares are <font color=\"red\">down 1.3%</font> pre-market to $16.19.</li><li>COMM has an Outperform <a href=\"https://seekingalpha.com/symbol/COMM/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3471355\" data-linked=\"Raymond James less bullish on CommScope; COMM -1%\" data-tweet=\"$COMM - Raymond James less bullish on CommScope; COMM -1% https://seekingalpha.com/news/3471355-raymond-james-less-bullish-on-commscope-commminus-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3471355-raymond-james-less-bullish-on-commscope-commminus-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471353\" data-ts=\"1560512791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRO\" target=\"_blank\">FRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471353-frontline-updates-on-damaged-tanker\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontline updates on damaged tanker</a></h4><ul> <li>Frontline (NYSE:<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a>) says a fire on one its tankers has been put out and towing of the vessel is expected to occur later today.</li> <li>The company's Front Altair was one of the two vessels damaged yesterday in the Gulf of Oman in what the U.S. is calling unprovoked attacks.</li> <li>Shares of Frontline are <font color=\"red\">down 3.38%</font> premarket to $7.72.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471353\" data-linked=\"Frontline updates on damaged tanker\" data-tweet=\"$FRO - Frontline updates on damaged tanker https://seekingalpha.com/news/3471353-frontline-updates-on-damaged-tanker?source=tweet\" data-url=\"https://seekingalpha.com/news/3471353-frontline-updates-on-damaged-tanker\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471348\" data-ts=\"1560511897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARQL\" target=\"_blank\">ARQL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471348-arqule-rallies-after-reporting-blood-cancer-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArQule rallies after reporting blood cancer results</a></h4><ul><li>ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) <font color=\"green\">+35.9%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17544736-arqule-announces-clinical-proof-concept-data-ongoing-phase-1-study-reversible-btk-inhibitor\" target=\"_blank\">releasing preliminary results</a> from its phase 1 dose escalation study for ARQ 531 demonstrates substantial anti-tumor activity and a favorable safety profile.</li><li>Four of six evaluable CLL patients, all with the BTK-C481S mutation, from cohort 7 (65 mg) experienced a partial response, according to results delivered at the 2019 European Hematology Association meeting in Amsterdam.</li><li>ARQL says it is \"now focused on finalizing the recommended phase 2 dose       and planning for the expansion of our clinical efforts with ARQ 531 into       later stage trials across multiple indications as a single agent and as       a combination therapy.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3471348\" data-linked=\"ArQule rallies after reporting blood cancer results\" data-tweet=\"$ARQL - ArQule rallies after reporting blood cancer results https://seekingalpha.com/news/3471348-arqule-rallies-after-reporting-blood-cancer-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3471348-arqule-rallies-after-reporting-blood-cancer-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471345\" data-ts=\"1560511312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BXG\" target=\"_blank\">BXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471345-bluegreen-vacationsplus-18-after-bass-settlement-stifel-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bluegreen Vacations +18% after Bass settlement, Stifel upgrade</a></h4><ul> <li>Stifel lifts Bluegreen Vacation (NYSE:<a href='https://seekingalpha.com/symbol/BXG' title='Bluegreen Vacations Corporation'>BXG</a>) to a Buy rating after having the private vacation ownership company slotted at Hold.</li> <li>The research firm's price target of $10 reps 25% upside potential for shares.</li> <li>Stifel's positive view on BXG contrasts sharply with the <a href=\"https://seekingalpha.com/symbol/BXG/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> of Very Bearish.</li> <li>Shares of BXG are <font color=\"green\">up 17.50%</font> premarket to $9.40 following a key <a href=\"https://seekingalpha.com/pr/17544633-bluegreen-vacations-corporation-enters-settlement-bass-pro-reinstate-marketing-activities\" target=\"_blank\">settlement</a> with Bass Pro related to marketing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471345\" data-linked=\"Bluegreen Vacations +18% after Bass settlement, Stifel upgrade\" data-tweet=\"$BXG $BBX $BXG - Bluegreen Vacations +18% after Bass settlement, Stifel upgrade https://seekingalpha.com/news/3471345-bluegreen-vacationsplus-18-after-bass-settlement-stifel-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3471345-bluegreen-vacationsplus-18-after-bass-settlement-stifel-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471344\" data-ts=\"1560511172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471344-surprise-tusa-keeps-underweight-rating-on-ge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Surprise! Tusa keeps Underweight rating on GE</a></h4><ul><li>In a research note entitled \"Thoughts On 'Commercial Success,'\" longtime bear Stephen Tusa at J.P. Morgan keeps an Underweight rating on General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric Company'>GE</a>), saying the company is not sticking to a \"general agreement on the need to limit the focus on headlines.\"</li><li>Despite an increase in market share and big order wins, the analyst writes that GE has \"acknowledged chasing deal announcements despite unfavorable price,\" and has claimed to \"no longer promote market share as the main goal.\"</li><li>As a result, recent developments \"raise questions around how much change has actually occurred.\"</li><li>GE <font color=\"red\">-0.6%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3471344\" data-linked=\"Surprise! Tusa keeps Underweight rating on GE\" data-tweet=\"$GE - Surprise! Tusa keeps Underweight rating on GE https://seekingalpha.com/news/3471344-surprise-tusa-keeps-underweight-rating-on-ge?source=tweet\" data-url=\"https://seekingalpha.com/news/3471344-surprise-tusa-keeps-underweight-rating-on-ge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471333\" data-ts=\"1560509805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471333-fedex-receives-inquiry-from-chinese-authorities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx receives inquiry from Chinese authorities</a></h4><ul> <li>The Chinese government sent an official <a href=\"https://www.reuters.com/article/us-huawei-tech-fedex-china-probe/china-sent-official-inquiry-to-fedex-regarding-parcels-delivery-xinhua-idUSKCN1TF17C\" target=\"_blank\">inquiry</a> to FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) over details about parcels that were delivered incorrectly, according to Xinhua.</li> <li>The shipper is under investigation after parcels sent by Huawei Technologies to Chinese customers were misdirected to the U.S.</li> <li>Shares of FedEx are <font color=\"red\">down 1.01%</font> premarket to $164.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3471333\" data-linked=\"FedEx receives inquiry from Chinese authorities\" data-tweet=\"$FDX - FedEx receives inquiry from Chinese authorities https://seekingalpha.com/news/3471333-fedex-receives-inquiry-from-chinese-authorities?source=tweet\" data-url=\"https://seekingalpha.com/news/3471333-fedex-receives-inquiry-from-chinese-authorities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471316\" data-ts=\"1560502909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471316-chipmakers-stumble-after-broadcom-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipmakers stumble after Broadcom warning</a></h4><ul><li>Semis are feeling the heat after Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Inc.'>AVGO</a>) cut its annual sales forecast, saying it would make $2B less than it expected following the U.S. ban on exports to Chinese telecom giant Huawei.</li><li>The stock <font color=\"red\">slumped 8.7%</font> in AH trading, dragging many peers down with it, as it became one of the first big chipmakers to quantify the financial impact of the Trump administration's escalating trade dispute.</li><li>The company may have been overly cautious, however, with broker Piper Jaffray <a href=\"https://www.bloomberg.com/news/articles/2019-06-14/five-things-you-need-to-know-to-start-your-day?srnd=markets-vp\" target=\"_blank\">saying</a> Broadcom was \"throwing out the entire kitchen with the kitchen sink.\"</li><li>Premarket: <a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a> <font color=\"red\">-1.9%</font>, <a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color=\"red\">-1.1%</font>; <a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a> <font color=\"red\">-2.5%</font>, <a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics N.V.'>STM</a> <font color=\"red\">-2.4%</font>, <a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a> <font color=\"red\">-2.6%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3471316\" data-linked=\"Chipmakers stumble after Broadcom warning\" data-tweet=\"$AVGO $QCOM $INTC - Chipmakers stumble after Broadcom warning https://seekingalpha.com/news/3471316-chipmakers-stumble-after-broadcom-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3471316-chipmakers-stumble-after-broadcom-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>109&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3471308\" data-ts=\"1560489253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAVB\" target=\"_blank\">NAVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3471308-navidea-biopharmaceuticals-prices-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navidea Biopharmaceuticals prices stock offering</a></h4><ul> <li>Navidea Biopharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/NAVB' title='Navidea Biopharmaceuticals, Inc.'>NAVB</a>) has priced public offering of       8M common shares at $0.75/share, for gross proceeds of $6M.</li><li>Underwriter over-allotment is an additional 1.2M common shares.</li><li>Closing date is on June 18.</li>     <li>Net proceeds will be used to fund its research       and development programs, and for general working capital purposes and other       operating expenses.</li>     <li>NAVB  <font color=\"green\">+16%</font> after hours to  $1.15</li><li>Source: <a href=\"https://seekingalpha.com/pr/17544697-navidea-biopharmaceuticals-prices-6_0-million-public-offering-common-stock\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3471308\" data-linked=\"Navidea Biopharmaceuticals prices stock offering\" data-tweet=\"$NAVB - Navidea Biopharmaceuticals prices stock offering https://seekingalpha.com/news/3471308-navidea-biopharmaceuticals-prices-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3471308-navidea-biopharmaceuticals-prices-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 AM </div></div></li>","count":57,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}